Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report

Tylenol

Kenvue Inc. (NYSE:KVUE) interim CEO Kirk Perry met privately this week with Health Secretary Robert F. Kennedy Jr. to argue that there is no proven link between the popular pain reliever Tylenol and autism.

Kennedy is prepared to release a report later this month suggesting that acetaminophen, an active ingredient in Tylenol, used during pregnancy, could be a potential factor in neurodevelopmental disorders.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.